Norway· NO-ID_099B9A65-B177-4240-9518-AB15F86B5485

Mirabella

A levonorgestrel and ethinylestradiol product containing ethinylestradiol + levonorgestrel + lactose., registered in Norway by Exeltis Healthcare S.L.. The same ATC class is registered in 12 of our 19 countries.

ATC G03AA07

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedMirabellaATCG03AA07REGISTER NO.NO-ID_099B9A65-B177-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Levonorgestrel and ethinylestradiol is registered in 12 of 19 countries.

Countries holding a registration under ATC G03AA07 (levonorgestrel and ethinylestradiol), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Levonorgestrel and ethinylestradiol · ATC G03AA07

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Ethinylestradiol + Levonorgestrel + Lactose.
Manufacturer
Exeltis Healthcare S.L.
Country
Norway (NO)
ATC code
G03AA07
ATC class
Levonorgestrel and ethinylestradiol
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_099B9A65-B177-4240-9518-AB15F86B5485
  • no_varenummer
    094439
    3 x 28
    NOK 323.3
  • gtin
    7046260944398

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

494 interactions on record for levonorgestrel and ethinylestradiol.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levonorgestrel and ethinylestradiol · interactions on record

494 records

  • 40 severe
  • 372 moderate
  • 49 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • HeminB06AB01severe
  • BosentanC02KX01severe
  • GriseofulvinD01AA08severe

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levonorgestrel and ethinylestradiol in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levonorgestrel and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Loette, Melleva
  • Belgium · Levesialle Continu, Levesialle Continu 20
  • Czechia · Asumate, Cillia
  • Germany · Asumate 30/21+7, Microgynon 28
  • Denmark · Leverette 28, Loette 28
  • Estonia · Leverette
  • Spain · Levesialle Diario, Levobel Diario
  • Finland · Levesia
  • France · Asterluna Continu
  • United Kingdom (Northern Ireland) · Logynon Ed, Microgynon 30 Ed
  • Hungary · Levonoree, Missee
  • Iceland · Leverette
  • Italy · Jadiza, Lasca
  • Lithuania · Leverette
  • Luxembourg · Levesialle Continu
  • Latvia · Leverette
  • Netherlands · Ethinylestradiol/Levonorgestrel Theramex
  • Poland · Leverette, Orlifique
  • Portugal · Gesffiset
  • Romania · Rigevidon 21+7
  • Sweden · Leverette, Levesia
  • Slovakia · Leverette, Levonille

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/04481f58-0d77-4ed8-b382-8f8439292c9a
GET /v1/drugs/04481f58-0d77-4ed8-b382-8f8439292c9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Levonorgestrel og etinyløstradiol",
  "merkevare_id": "ID_099B9A65-B177-4240-9518-AB15F86B5485",
  "name_form_strength": "Mirabella tab 100 mikrog/20 mikrog",
  "prescription_group": "C"
}

See everything about levonorgestrel and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.